Centiva Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Centiva Capital’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-46,410	Closed	-$3.35M	–	1611
2020 Q4	$3.35M	Buy	+46,410	New	+$2.43M	0.13%	96

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Centiva Capital's BEAT Position: Q1 2021 in Review

Centiva Capital sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 46,410 shares — an estimated $3.35M sold.

Centiva Capital first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $3.35M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Centiva Capital reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Centiva Capital sold 46,410 BioTelemetry, Inc. shares in Q1 2021, an estimated $3.35M.
Centiva Capital first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Centiva Capital's BioTelemetry, Inc. position peaked at $3.35M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Centiva Capital's 13F filing for Q1 2021, filed 17 May 2021.